Multivalvular Disease: Percutaneous Management in 2019 and Beyond

Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Erlebach, Magdalena, Lange, Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Structural
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918484/
https://www.ncbi.nlm.nih.gov/pubmed/31867059
http://dx.doi.org/10.15420/icr.2019.13.R1
Descripción
Sumario:Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.

Ejemplares similares